30508205|t|Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration.
30508205|a|Commonalities and, in some cases, pathological overlap between neurodegenerative diseases have led to speculation that targeting of underlying mechanisms might be of potentially shared therapeutic benefit. Alzheimer's disease is characterized by the formation of plaques, composed primarily of the amyloid-beta 1-42 (Abeta) peptide in the brain, resulting in neurodegeneration. Previously, we have shown that overexpression of the lysosomal-trafficking protein, human Vps41 (hVps41), is neuroprotective in a transgenic worm model of Parkinson's disease, wherein progressive dopaminergic neurodegeneration is induced by alpha-synuclein overexpression. Here, we report the results of a systematic comparison of hVps41-mediated neuroprotection between alpha-synuclein and Abeta in transgenic nematode models of Caenorhabditis elegans. Our results indicate that an ARF-like GTPase gene product, ARL-8, mitigates endocytic Abeta neurodegeneration in a VPS-41-dependent manner, rather than through RAB-7 and AP3 as with alpha-synuclein. Furthermore, the neuroprotective effect of ARL-8 or hVps41 appears to be dependent on their colocalization and the activity of ARL-8. Additionally, we demonstrate that the LC3 orthologue, LGG-2, plays a critical role in Abeta toxicity with ARL-8. Further analysis of functional effectors of Abeta protein processing via the lysosomal pathway will assist in the elucidation of the underlying mechanism involving VPS-41-mediated neuroprotection. These results reveal functional distinctions in the intracellular management of neurotoxic proteins that serve to better inform the path for development of therapeutic interventions to halt neurodegeneration.
30508205	29	34	Vps41	Gene	27072
30508205	63	74	Alzheimer's	Disease	MESH:D000544
30508205	79	98	Parkinson's disease	Disease	MESH:D010300
30508205	109	126	neurodegeneration	Disease	MESH:D019636
30508205	191	217	neurodegenerative diseases	Disease	MESH:D019636
30508205	334	353	Alzheimer's disease	Disease	MESH:D000544
30508205	445	450	Abeta	Gene	351
30508205	487	504	neurodegeneration	Disease	MESH:D019636
30508205	590	595	human	Species	9606
30508205	596	601	Vps41	Gene	27072
30508205	603	609	hVps41	Gene	27072
30508205	661	680	Parkinson's disease	Disease	MESH:D010300
30508205	702	732	dopaminergic neurodegeneration	Disease	MESH:D009422
30508205	747	762	alpha-synuclein	Gene	6622
30508205	837	843	hVps41	Gene	27072
30508205	877	892	alpha-synuclein	Gene	6622
30508205	897	902	Abeta	Gene	351
30508205	936	958	Caenorhabditis elegans	Species	6239
30508205	1019	1024	ARL-8	Gene	221079
30508205	1046	1051	Abeta	Gene	351
30508205	1052	1069	neurodegeneration	Disease	MESH:D019636
30508205	1120	1125	RAB-7	Gene	174834
30508205	1142	1157	alpha-synuclein	Gene	6622
30508205	1202	1207	ARL-8	Gene	221079
30508205	1211	1217	hVps41	Gene	27072
30508205	1286	1291	ARL-8	Gene	178405
30508205	1347	1352	LGG-2	Gene	177989
30508205	1379	1384	Abeta	Gene	351
30508205	1385	1393	toxicity	Disease	MESH:D064420
30508205	1399	1404	ARL-8	Gene	178405
30508205	1450	1455	Abeta	Gene	351
30508205	1683	1693	neurotoxic	Disease	MESH:D020258
30508205	1793	1810	neurodegeneration	Disease	MESH:D019636
30508205	Negative_Correlation	MESH:D019636	221079
30508205	Association	MESH:D010300	27072
30508205	Association	MESH:D000544	351
30508205	Negative_Correlation	221079	351
30508205	Association	MESH:D019636	351
30508205	Association	177989	351
30508205	Association	MESH:D010300	6622
30508205	Positive_Correlation	MESH:D009422	6622
30508205	Association	MESH:D064420	177989
30508205	Association	178405	27072
30508205	Association	MESH:D000544	27072
30508205	Association	178405	221079

